Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Finished Drug Prices
NA
1. 190786-44-8
2. Bepotastine Besylate
3. Bepreve
4. Talion
5. Betotastine Besilate
6. Bepotastine Benzenesulfonate
7. Tau-284
8. Bepotastine Besylate [usan]
9. Bepotastine Benzenesulfonate Salt
10. Bepotastine (besilate)
11. 6w18mo1qr3
12. Chebi:31281
13. Tau 284
14. 190786-44-8 (besylate)
15. Bepotastine Besylate (usan)
16. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Compound With Benzenesulfonic Acid (1:1)
17. 1-piperidinebutanoic Acid, 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-, Benzenesulfonate (1:1)
18. 1-piperidinebutanoic Acid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-, Benzenesulfonate (1:1)
19. Unii-6w18mo1qr3
20. Bepomax
21. Tau-284ds
22. Bepotastine Besitate
23. Bepreve (tn)
24. Bepotastine Beslilate
25. Talion (tn)
26. (+)-(s)-4-(4-((4-chlorophenyl)(2-pyridyl)methoxy)piperidino)butyric Acid Monobenzenesulfonate
27. 4-((4-chlorophenyl)-2-pyridinylmethoxy)- (s)-1-piperidinebutanoic Acid Monobenzenesulfonate
28. Tau284
29. 4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic Acid Benzenesulfonate
30. Bepotastine Besilate (jp17)
31. Schembl1287638
32. Chembl1201759
33. Dtxsid80172577
34. Bepotastine Besilate [jan]
35. Hms3885a05
36. Hy-a0015
37. Bepotastine Besilate [vandf]
38. Bepotastine Besilate [mart.]
39. Mfcd01938491
40. S3037
41. Bepotastine Besilate [who-dd]
42. Akos025401655
43. Ccg-269988
44. Cs-0383
45. Bepotastine Benzenesulphonate Salt
46. 1-piperidinebutanoic Acid, 4-((4-chlorophenyl)-2-pyridinylmethoxy)- (s)-, Monobenzenesulfonate
47. Ac-24015
48. As-17863
49. Benzenesulfonic Acid;4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic Acid
50. Bepotastine Besilate [orange Book]
51. B5943
52. Sw220161-1
53. Bepotastine Benzenesulfonate Salt [mi]
54. D01654
55. 786b448
56. J-012325
57. Q27114261
58. (+)-4-(4-((s)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Monobenzenesulfonate
59. (+)-4-(4-((s)-(4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid Monobenzenesulphonate
60. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)-methoxy]piperidino]butanoic Acid Monobenzenesulfonic Acid Salt
61. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic Acid Monobenzenesulfonic Acid Salt
62. 1-piperidinebutanoic Acid, 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-, Benzenesulphonate (1:1)
63. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid Benzenesulfonate Salt
64. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid Benzenesulphonate Salt
Molecular Weight | 547.1 g/mol |
---|---|
Molecular Formula | C27H31ClN2O6S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 546.1591356 g/mol |
Monoisotopic Mass | 546.1591356 g/mol |
Topological Polar Surface Area | 125 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 632 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Bepreve |
PubMed Health | Bepotastine Besilate (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a sterile, topically administered drug for ophthalmic use. Each mL of BEPREVE contains 15 mg bepotastine besilate. Bepotastine besilate is designated chemically as (+) -4-[[(S)-p-chloro-alpha... |
Active Ingredient | Bepotastine besilate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 1.5% |
Market Status | Prescription |
Company | Bausch And Lomb |
2 of 2 | |
---|---|
Drug Name | Bepreve |
PubMed Health | Bepotastine Besilate (Into the eye) |
Drug Classes | Ophthalmologic Agent |
Drug Label | BEPREVE (bepotastine besilate ophthalmic solution) 1.5% is a sterile, topically administered drug for ophthalmic use. Each mL of BEPREVE contains 15 mg bepotastine besilate. Bepotastine besilate is designated chemically as (+) -4-[[(S)-p-chloro-alpha... |
Active Ingredient | Bepotastine besilate |
Dosage Form | Solution/drops |
Route | Ophthalmic |
Strength | 1.5% |
Market Status | Prescription |
Company | Bausch And Lomb |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?